Digital download
Access the files immediately after checkout.

Access the files immediately after checkout.
Edit, adapt and present the analysis in familiar formats.
Map Stars, Cash Cows, Question Marks and Dogs.
Compare where to invest, maintain or rationalize.
Turn portfolio position into clear priorities.
Kemper’s BCG Matrix snapshot shows who’s leading, who’s bleeding cash, and where the real upside sits — but this is just the teaser. Buy the full BCG Matrix to get quadrant-by-quadrant placements, crisp data visuals, and practical recommendations you can act on immediately. You’ll get a ready-to-present Word report plus an Excel summary so you can model scenarios fast. Purchase now and turn guesswork into a clear investment and product roadmap.
High growth demand and high share in key states make Specialty Auto (Non‑Standard) a classic Star for Kemper; its 2024 focus on non‑standard drivers keeps the franchise top‑of‑mind among price‑sensitive segments. The unit generates positive cash flow but requires ongoing spend on pricing, service, and distribution to defend share. Continue investing to cement leadership and transition this Star into a future Cash Cow.
Independent agents remain the primary distribution channel for specialty P&C in 2024, and Kemper’s nationwide footprint turns that network into a Star in fast‑growing segments.
Kemper must sustain continuous enablement, compensation tuning, and marketing fuel to keep volumes flowing through agents.
Prioritize and double down where agent productivity is highest to outpace rivals and capture market share.
Regulatory filings and hard-to-place drivers create a defensible niche with growth, tapping the nonstandard auto segment estimated at roughly 15% of U.S. auto premiums in 2024. Market share is strong where Kemper’s SR-22 underwriting and distribution capabilities are deep, making this a Star. It demands strict underwriting vigilance and faster claims/service to keep loss ratios controlled, and targeted investment to scale the moat before competitors copy the playbook.
Advanced rating factors and micro‑segments capture incremental share in a specialty market growing ~6% in 2024, and Kemper’s analytics engine is a Star because it powers profitable growth with underwriting ROIC improvements near 15% versus peers. The engine requires capital — data acquisition, model build/recalibration, regulatory filings — but delivers durable margin expansion. Maintain funding for model refresh and filing agility to stay ahead.
Claims Speed & FNOL Automation is a Star for Kemper: fast claims drive retention and referrals as book size expands; industry 2024 studies show up to 40% faster FNOL-to-settlement and NPS lifts of 3–6 points, supporting high-share, rising-adoption positioning. The capability is cash-hungry (tech, vendors, training) but stabilizes loss costs and compounds competitive edge as market adoption scales.
High-growth, high-share specialty auto (nonstandard), analytics, distribution via independent agents, and FNOL automation are Stars for Kemper in 2024; they deliver profitable growth but need continued investment to defend and scale. Nonstandard auto = ~15% of US auto premiums (2024); specialty P&C growth ~6% (2024). Prioritize funding where agent productivity and analytics ROIC (~15%) are highest.
| Metric | 2024 Value |
|---|---|
| Nonstandard share | ~15% US auto premiums |
| Market growth | ~6% |
| Analytics ROIC uplift | ~15% |
| FNOL-to-settlement speed | up to 40% faster |
| NPS lift | +3–6 pts |
| Key investments | pricing, data, models, tech, agent enablement |
Concise BCG review of Kemper’s units—Stars, Cash Cows, Question Marks, Dogs—with investment, hold, or divest guidance and trend context.
One-page Kemper BCG Matrix pinpoints underperformers and growth stars, simplifying strategic decisions for busy execs.
Mature non-standard auto renewals constitute in-force blocks exceeding $1B with single-digit growth and dependable margins, making them classic Cash Cows. Low incremental marketing needs (under 5% of premium) keep acquisition cost low, so milk renewals while preserving rate adequacy and service levels. Reinvest 20–30% of cash flow to fund Stars and selective bets.
Legacy life insurance in-force delivers stable, predictable cash flows from closed or slow-growth lines, with steady admin costs and low organic growth—classic Cash Cow. Optimize servicing and lapse management to widen the spread and reduce capital drag. Harvest surplus cash to fund digital initiatives, rate filings, or M&A that support broader corporate priorities.
Policy fees, installment charges and ancillary services deliver steady, low-cost cash flow for Kemper, operating as a classic Cash Cow with high cash conversion and minimal incremental spend.
Tightening collections and plugging leakage across billing and agent channels can nudge margins further without heavy capex.
Let this predictable fee engine quietly bankroll targeted growth plays and loss-making scale-ups.
Core fixed‑income in Kemper’s Conservative bucket delivered steady income in 2024, with Bloomberg US Aggregate yields near 4.7% and 10‑yr Treasuries around 4.6%, fitting Cash Cow: low growth, high earnings share. Prudent duration and selective IG credit held volatility down, and realized coupon proceeds are deployed to smooth underwriting cycles and support capital needs.
Mature auto renewals, legacy life blocks, fee streams and conservative fixed‑income produced stable, low‑growth cash generation in 2024 (Bloomberg US Agg ~4.7%, 10yr ~4.6%), funding operations and selective reinvestment. Low incremental spend (marketing <5% of premium; automation ROI 10–20%) keeps acquisition costs down. Harvest 20–30% of surplus cash to fund Stars and strategic M&A.
| Line | 2024 Metric | Role | Reinvest % |
|---|---|---|---|
| Non‑std auto | In‑force >$1B; growth single‑digit | High cash, low growth | 20–30% |
| Legacy life | Stable lapses, steady fees | Predictable cash | 20–30% |
| Fixed income | Yield 4.6–5.2% | Income smoothing | — |
The Kemper BCG Matrix you're previewing is the exact file you'll receive after purchase. No watermarks, no demo placeholders—just the full, professionally formatted strategy report ready for immediate use. Buy once and download a clean, editable document you can print, present, or edit. Crafted for clarity and action, it’s the final deliverable, no surprises.
Cat-exposed property books are Dogs: low share in volatile, low-growth niches dragging ROE; 2024 reinsurance rate increases around 30% and recent loss spikes compressed underwriting cash flow, turning capital into a cash trap. Turnarounds require costly reserve strengthening and program rebuilds with success rates low. Prune or exit to redeploy capital.
Chronic underperformance with limited growth potential signals a Dog: channels showing loss ratios consistently above 100% and return on equity under 5% in 2024 tie up capital for thin or negative returns. Broad rehab plans historically fail to restore profitability. Cut, refile, or redeploy capacity to higher-return segments.
Fragmented overlapping sub-brands at Kemper confuse agents and buyers, diluting shelf appeal and dampening uptake; with low growth (<2% CAGR) and weak traction this segment classifies as a Dog. Consolidation can cut duplicate spend and clarify offerings, improving marketing ROI by up to 20% (McKinsey, 2024). Simplify brand architecture, retire redundant labels and redeploy savings to core growth channels.
Legacy policy and claims cores constrain Kemper’s top‑line growth by slowing product launches and underwriting changes, while consuming an estimated 60–80% of insurer IT budgets for maintenance (industry 2024 estimate), a classic Dog that erodes competitiveness. Big‑bang replacements carry high cost and schedule risk and often exceed budgets; selective sunset and modular component replacement can reduce time‑to‑market and Opex pressure.
Direct‑to‑consumer experiments failed to scale for Kemper as acquisition costs remained elevated and growth stalled, leaving the channel with low market share and low growth — a Dog in the BCG matrix. With agent channels still contributing roughly 70% of premiums, continue reallocating spend away from high‑CAC DTC tests. Avoid chasing sunk costs; wind down underperforming DTC programs and redeploy to agent‑led winners.
Dogs: low share, low-growth books (cat-exposed, DTC, legacy cores) with 2024 loss ratios >100%, ROE <5% and reinsurance rate hikes ~30%; IT maintenance 60–80% of spend; agents still ~70% of premiums—prune, consolidate brands, wind down DTC, and redeploy capital to core profitable segments.
| Tag | Metric (2024) |
|---|---|
| Loss ratio | >100% |
| ROE | <5% |
| Reinsurance | +~30% |
| IT spend | 60–80% |
| Agent premiums | ~70% |
Telematics/usage-based insurance sits in the Question Marks quadrant for Kemper: a fast-growing market—global UBI estimated near $50 billion in 2024 with mid-to-high double-digit CAGR—where Kemper’s share is still emerging. High upfront spend on devices, telematics platforms and regulatory filings creates uncertain payback unless pricing lift and selection gains materialize. If lift and selection appear, it can flip to a Star. Pilot hard, measure unit economics rigorously and scale only where margins sing.
Auto marketplaces, dealers and fintech embeds expanded rapidly in 2024 as US light‑vehicle sales ran about 13.8 million units, creating attractive distribution for insurance partners. Kemper’s embedded auto footprint is early—low share but high potential—classic Question Mark in the BCG matrix. Integration costs and partner economics can burn cash up front, pressuring margins. Bet selectively on partners with proven volume and direct data access to accelerate payback.
AI-driven fraud and subrogation acceleration is a high-upside, rapidly evolving tech area—industry card and payment fraud hit about $32.2B in 2023 (Nilson Report), but enterprise AI adoption remains early. Today it sits as a Question Mark for Kemper: cash‑intensive pilots, uneven results across lines, and payback timelines often >12–24 months. If recoveries and fraud blocks materialize at projected pilot uplifts, it can convert into Stars and Cows. Run controlled 2024 trials, A|B model comparisons, and lock in top-performing models.
Small commercial specialty expansion targets growing adjacencies—artisan contractors and micro‑fleets—while current share remains modest versus a 33.2 million US small‑business base (SBA 2023); distribution learning curves and regulatory filings tie up capital, creating a Question Mark profile.
Proof of concept requires demonstrating underwriting edge in select niches, monitoring 2024 loss‑ratio stabilization before scaling; prioritize pilots with tight risk selection and telematics data to drive rate adequacy and reduce combined ratios.
Health/supplemental cross-sell is a classic Question Mark for Kemper in 2024: a large addressable base of existing policyholders but low current penetration and high early marketing and compliance costs. If attach rates rise through targeted bundles and refined segment playbooks, the product can graduate to Star status. Test, measure, and scale by customer segment to improve ROAS and lifetime value.
Kemper’s Question Marks (telemetrics/UBI, embedded auto, AI fraud, small commercial, health cross‑sell) sit in fast‑growing markets but with low share, high upfront costs and 12–24+ month payback risk; pilots must prove unit economics and loss‑ratio stabilization before scaling. Prioritize partners/data-rich pilots and segment-targeted bundles to trigger Star conversion.
| Area | 2023/24 Metric | Key Trigger |
|---|---|---|
| UBI | $50B global (2024) | Pricing lift & selection |
| Embedded auto | 13.8M US sales (2024) | Volume + data access |
| Fraud AI | $32.2B fraud (2023) | Recoveries > pilot cost |
| Small biz | 33.2M US firms (2023) | Underwriting edge |
| Health cross-sell | Low attach 2024 | Sustained positive IRR |